A multi-centre study comparing the effects of AZD2927 and placebo on the electrical activity in the heart in patients

Study identifier:D4120C00002

ClinicalTrials.gov identifier:N/A

EudraCT identifier:2011-001716-59

CTIS identifier:N/A

Study Complete

Official Title

A Multi-Centre, Double-Blind, Randomised, Placebo-Controlled Phase II Study to Assess the Effects on Atrial and Ventricular Refractoriness of an Intravenous Infusion of AZD2927 in Patients Undergoing an Invasive Electrophysiological Procedure

Medical condition

Arrhythmia

Phase

Phase 2

Healthy volunteers

No

Study drug

AZD2927, Placebo

Sex

All

Actual enrollment

20

Study type

Interventional

Age

20 Years - 80 Years

Date

Study Start Date: 01 Sept 2011
Primary Completion Date: 01 Jan 2012
Study Completion Date: 01 Jan 2012

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Basic Science

Verification:

Verified 01 Nov 2012 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria